| Identification | Back Directory | [Name]
3-BROMO-4-FORMYLPYRIDINE | [CAS]
70201-43-3 | [Synonyms]
CHEMBRDG-BB 4003258
3-BROMO-4-FORMYLPYRIDINE
3-BROMOISONICOTINALDEHYDE
3-Bromoisonicotinaldehyde 95%
3-Bromoisonicotinaldehyde ,98%
3-Bromo-4-pyridinecarbaldehyde
3-BROMO-PYRIDINE-4-CARBALDEHYDE
3-BROMOPYRIDINE-4-CARBOXALDEHYDE
3-BROMO-4-PYRIDINECARBOXALDEHYDE
5-BroMopyridine-4-carboxaldehyde
4-Pyridinecarboxaldehyde, 3-bromo-
3-Bromopyridine-4-carboxaldehyde 95%
3-Bromopyridine-4-carboxaldehyde ,98%
3-BROMO-4-FORMYLPYRIDINE ISO 9001：2015 REACH | [EINECS(EC#)]
627-770-6 | [Molecular Formula]
C6H4BrNO | [MDL Number]
MFCD05864506 | [MOL File]
70201-43-3.mol | [Molecular Weight]
186.01 |
| Chemical Properties | Back Directory | [Melting point ]
81-82 °C(lit.)
| [Boiling point ]
246.2±20.0 °C(Predicted) | [density ]
1.683±0.06 g/cm3(Predicted) | [storage temp. ]
Keep in dark place,Sealed in dry,Room Temperature | [solubility ]
Acetonitrile (Slightly), Chloroform (Slightly) | [form ]
Solid | [pka]
0.90±0.18(Predicted) | [color ]
Light Brown | [InChIKey]
NOBDKWLIAQKADB-UHFFFAOYSA-N |
| Hazard Information | Back Directory | [Chemical Properties]
Off-white solid | [Uses]
3-Bromo-4-pyridinecarboxaldehyde acts as a reagent in the synthesis of 3,4,5-trisubstituted 4,5-dihydro-1,2,4-oxadiazoles agonists which interact with the G-protein-coupled bile acid receptor 1 (TGR5) inducing insulin secretion which may be used as a potential treatment for diabetus mellitus. |
|
|